Bronchoscopic lung volume reduction procedures for chronic obstructive pulmonary disease

Area of Science:

• Pulmonary Medicine
• Interventional Pulmonology
• Respiratory Disease Research

Background:

• Chronic Obstructive Pulmonary Disease (COPD) significantly impacts patient health and quality of life.
• Bronchoscopic Lung Volume Reduction (BLVR) procedures have emerged as potential treatments for moderate to severe COPD.
• Evaluating the efficacy and safety of various BLVR techniques is crucial for clinical decision-making.

Purpose of the Study:

• To assess the short- and long-term health outcomes of BLVR in moderate to severe COPD patients.
• To determine the effectiveness and cost-effectiveness of individual BLVR techniques.
• To synthesize evidence from randomized controlled trials (RCTs) on BLVR procedures.

Main Methods:

• Systematic literature search of Cochrane Airways Group Specialised Register and respiratory journals up to December 2016.
• Inclusion of randomized controlled trials (RCTs), including full-text, abstract-only, and unpublished data.
• Data extraction and meta-analysis performed by two independent reviewers using RevMan 5 software.

Main Results:

• Endobronchial coils and valves demonstrated significant improvements in FEV1 and quality of life (SGRQ), but with increased adverse events.
• AeriSeal showed significant FEV1 and SGRQ improvements but also higher adverse events; airway bypass stents showed no significant benefits.
• Vapour ablation improved FEV1 and SGRQ but increased adverse events; intrabronchial valves showed mixed results with more adverse events.

Conclusions:

• Selected BLVR procedures offer significant short-term health benefits for COPD patients, albeit with increased adverse events.
• Current evidence is insufficient to determine the long-term effects or mortality impact of BLVR procedures.
• Limitations include lack of long-term data, heterogeneity, and potential bias from open-label studies.